fingolimod hydrochloride has been researched along with oxazolone in 2 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (oxazolone) | Trials (oxazolone) | Recent Studies (post-2010) (oxazolone) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 1,148 | 1 | 318 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daniel, C; Geisslinger, G; Radeke, HH; Sartory, NA; Schmidt, R; Stein, JM; Zahn, N | 1 |
| He, X; Li, S; Wang, L; Xiao, J; Zheng, Z; Zhong, W | 1 |
2 other study(ies) available for fingolimod hydrochloride and oxazolone
| Article | Year |
|---|---|
FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions.
Topics: Adjuvants, Immunologic; Animals; Cells, Cultured; Colitis, Ulcerative; Disease Models, Animal; Fingolimod Hydrochloride; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Oxazolone; Propylene Glycols; Sphingosine; Th2 Cells | 2007 |
Novel immunomodulators based on an oxazolin-2-one-4-carboxamide scaffold.
Topics: Amides; Amino Acids; Benzamides; Catalytic Domain; Chemistry, Pharmaceutical; Drug Design; Fingolimod Hydrochloride; Humans; Hydrogen Bonding; Immunologic Factors; Immunosuppressive Agents; Inhibitory Concentration 50; Models, Chemical; Models, Molecular; Molecular Conformation; Oxazolone; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine | 2012 |